Evidence map›Paper›PMID 30917987›Full record

ArticleAntimicrobial agents and chemotherapy2019

A Combination Antibiogram Evaluation for

Laura Puzniak, Daryl D DePestel, Arjun Srinivasan, Gang Ye, John Murray, Sanjay Merchant, C Andrew DeRyke, Vikas Gupta

Open access · hybridAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Antimicrobial Treatment ofAntibiotics (Basel, Switzerland) · 2022
    Review
  9. Review
  10. Review
  11. Review
  12. Antimicrobial Susceptibility Profiles amongPathogens (Basel, Switzerland) · 2022
    Article
  13. Creation of a Combination Antibiogram forThe journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2021
    Article
  14. Comparative Evaluation of theAntimicrobial agents and chemotherapy · 2020
    Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Laura PuzniakMerck & Co., Inc., Kenilworth, New Jersey, USA.
Daryl D DePestelMerck & Co., Inc., Kenilworth, New Jersey, USA.
Arjun SrinivasanDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Gang YeBecton, Dickinson and Company, Franklin Lakes, New Jersey, USA.
John MurrayBecton, Dickinson and Company, Franklin Lakes, New Jersey, USA.
Sanjay MerchantMerck & Co., Inc., Kenilworth, New Jersey, USA.
C Andrew DeRykeMerck & Co., Inc., Kenilworth, New Jersey, USA.
Vikas GuptaBecton, Dickinson and Company, Franklin Lakes, New Jersey, USA vikas.gupta@bd.com.
Merck & Co., Inc., Rahway, NJ, USA (United States) · USBecton Dickinson (United States) · USCenters for Disease Control and Prevention · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsCarbapenemsCephalosporinsCross InfectionCross-Sectional StudiesDrug Resistance, Multiple, BacterialHospitalsHumansIntensive Care UnitsMicrobial Sensitivity TestsPiperacillin, Tazobactam Drug CombinationPneumonia, Ventilator-AssociatedPseudomonas aeruginosaPseudomonas InfectionsRetrospective StudiesUnited StatesAnti-Bacterial AgentsCarbapenemsCephalosporinsPiperacillin, Tazobactam Drug Combinationantibiogramantibiotic resistanceantimicrobial susceptibilitycombination susceptibilitiesintensive care unitPseudomonas aeruginosa

Identifiers

PMID30917987
PMCPMC6496158
OpenAlexW2923445799

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.